These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36551206)

  • 21. Antitumour activity of TH1579, a novel MTH1 inhibitor, against castration-resistant prostate cancer.
    Hu M; Ning J; Mao L; Yu Y; Wu Y
    Oncol Lett; 2021 Jan; 21(1):62. PubMed ID: 33281973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Proliferation-Inhibitory and Apoptosis-Inducing Effects of Targeting MTH1 on Multiple Myeloma Cells].
    Wang X; Wu Y; Zhang L; Li YX; Han B; Shi X; Wang W; Wang LS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1598-1604. PubMed ID: 33067960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of residue in the position of 116 on the inhibitory potency of TH588 for MTH1.
    Niu RJ; Zheng QC; Zhang HX
    J Mol Graph Model; 2018 Oct; 85():75-83. PubMed ID: 30103119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Existence of MTH1-independent 8-oxodGTPase Activity in Cancer Cells as a Compensatory Mechanism against On-target Effects of MTH1 Inhibitors.
    Samaranayake GJ; Troccoli CI; Zhang L; Huynh M; Jayaraj CJ; Ji D; McPherson L; Onishi Y; Nguyen DM; Robbins DJ; Karbaschi M; Cooke MS; Barrientos A; Kool ET; Rai P
    Mol Cancer Ther; 2020 Feb; 19(2):432-446. PubMed ID: 31744893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crystal Structures and Inhibitor Interactions of Mouse and Dog MTH1 Reveal Species-Specific Differences in Affinity.
    Narwal M; Jemth AS; Gustafsson R; Almlöf I; Warpman Berglund U; Helleday T; Stenmark P
    Biochemistry; 2018 Feb; 57(5):593-603. PubMed ID: 29281266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteomic profiling of small-molecule inhibitors reveals dispensability of MTH1 for cancer cell survival.
    Kawamura T; Kawatani M; Muroi M; Kondoh Y; Futamura Y; Aono H; Tanaka M; Honda K; Osada H
    Sci Rep; 2016 May; 6():26521. PubMed ID: 27210421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VISAGE Reveals a Targetable Mitotic Spindle Vulnerability in Cancer Cells.
    Patterson JC; Joughin BA; Prota AE; Mühlethaler T; Jonas OH; Whitman MA; Varmeh S; Chen S; Balk SP; Steinmetz MO; Lauffenburger DA; Yaffe MB
    Cell Syst; 2019 Jul; 9(1):74-92.e8. PubMed ID: 31302152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MTH1 favors mesothelioma progression and mediates paracrine rescue of bystander endothelium from oxidative damage.
    Magkouta SF; Pappas AG; Vaitsi PC; Agioutantis PC; Pateras IS; Moschos CA; Iliopoulou MP; Kosti CN; Loutrari HV; Gorgoulis VG; Kalomenidis IT
    JCI Insight; 2020 Jun; 5(12):. PubMed ID: 32554927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. c-MYC delays prometaphase by direct transactivation of MAD2 and BubR1: identification of mechanisms underlying c-MYC-induced DNA damage and chromosomal instability.
    Menssen A; Epanchintsev A; Lodygin D; Rezaei N; Jung P; Verdoodt B; Diebold J; Hermeking H
    Cell Cycle; 2007 Feb; 6(3):339-52. PubMed ID: 17297307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MTH1 expression is required for effective transformation by oncogenic HRAS.
    Giribaldi MG; Munoz A; Halvorsen K; Patel A; Rai P
    Oncotarget; 2015 May; 6(13):11519-29. PubMed ID: 25893378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Augment of Oxidative Damage with Enhanced Photodynamic Process and MTH1 Inhibition for Tumor Therapy.
    Hu JJ; Chen Y; Li ZH; Peng SY; Sun Y; Zhang XZ
    Nano Lett; 2019 Aug; 19(8):5568-5576. PubMed ID: 31262183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MutT Homolog 1 (MTH1) maintains multiple KRAS-driven pro-malignant pathways.
    Patel A; Burton DG; Halvorsen K; Balkan W; Reiner T; Perez-Stable C; Cohen A; Munoz A; Giribaldi MG; Singh S; Robbins DJ; Nguyen DM; Rai P
    Oncogene; 2015 May; 34(20):2586-96. PubMed ID: 25023700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple DNA damage-dependent and DNA damage-independent stress responses define the outcome of ATR/Chk1 targeting in medulloblastoma cells.
    Krüger K; Geist K; Stuhldreier F; Schumacher L; Blümel L; Remke M; Wesselborg S; Stork B; Klöcker N; Bormann S; Roos WP; Honnen S; Fritz G
    Cancer Lett; 2018 Aug; 430():34-46. PubMed ID: 29753759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding the molecular mechanism for the differential inhibitory activities of compounds against MTH1.
    Wang M; Zhou S; Chen Q; Wang L; Liang Z; Wang J
    Sci Rep; 2017 Jan; 7():40557. PubMed ID: 28074893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. (S)-crizotinib reduces gastric cancer growth through oxidative DNA damage and triggers pro-survival akt signal.
    Ji J; Chen W; Lian W; Chen R; Yang J; Zhang Q; Weng Q; Khan Z; Hu J; Chen X; Zou P; Chen X; Liang G
    Cell Death Dis; 2018 May; 9(6):660. PubMed ID: 29855474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. c-Myc accelerates S-phase and requires WRN to avoid replication stress.
    Robinson K; Asawachaicharn N; Galloway DA; Grandori C
    PLoS One; 2009 Jun; 4(6):e5951. PubMed ID: 19554081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Karonudib has potent anti-tumor effects in preclinical models of B-cell lymphoma.
    Oksvold MP; Berglund UW; Gad H; Bai B; Stokke T; Rein ID; Pham T; Sanjiv K; Øy GF; Norum JH; Smeland EB; Myklebust JH; Helleday T; Våtsveen TK
    Sci Rep; 2021 Mar; 11(1):6317. PubMed ID: 33737576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MTH1, an 8-oxo-2'-deoxyguanosine triphosphatase, and MYH, a DNA glycosylase, cooperate to inhibit mutations induced by chronic exposure to oxidative stress of ionising radiation.
    Shakeri Manesh S; Sangsuwan T; Pour Khavari A; Fotouhi A; Emami SN; Haghdoost S
    Mutagenesis; 2017 May; 32(3):389-396. PubMed ID: 28340109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of cancer cell death by a novel compound, C604, in a c-Myc-overexpressing cellular environment.
    Jo MJ; Paek AR; Choi JS; Ok CY; Jeong KC; Lim JH; Kim SH; You HJ
    Eur J Pharmacol; 2015 Dec; 769():257-65. PubMed ID: 26607468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression and function of MutT homolog 1 in distinct subtypes of breast cancer.
    Zhang X; Song W; Zhou Y; Mao F; Lin Y; Guan J; Sun Q
    Oncol Lett; 2017 Apr; 13(4):2161-2168. PubMed ID: 28454376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.